Skip Navigation
Leading research to understand, treat, and prevent infectious, immunologic, and allergic diseases
Skip Content Marketing
  • Share this:
  • submit to facebook
  • Tweet it
  • submit to reddit
  • submit to StumbleUpon
  • submit to Google +

Current Small Business F​unding Opportunities

Below are Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) funding opportunities that are currently open.

The NIH SBIR and STTR programs commonly use parent funding opp​​ortunity announcements (PAs), also known as Omnibus grant solicitations. The SBIR and STTR Omnibus solicitations are intended to support small business innovation research across a broad spectrum of topic areas. Omnibus solicitations are designed to encourage investigator-initiated SBIR and STTR grant applications in response to identified topics.

Note that NIAID does not support clinical trials through the SBIR or STTR programs, with the exception of our NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44). For details, read "Can my small business obtain funding for a clinical trial?"

See NIH SBIR/STTR for program updates and see the NIAID Funding Opportunities List for more NIAID funding opportunities.

Announcement Number, Title, and Link Division Type Due Date*
PA-16-303, PHS 2016-02 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR)  DAIDS, DAIT, DMID R41, R42 Standard dates through 2017-04-06.
PA-16-302, PHS 2016-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR) DAIDS, DAIT, DMID R43, R44 Standard dates through 2017-04-06.
PAR-16-271, NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement DAIDS, DAIT, DMID U44 See PAR. Through 2019-05-14.
PA-16-186, Tools for Cell Line Identification DAIDS, DAIT, DMID R43, R44 Standard dates through 2019-04-06.
PA-16-184, Strategies for the Improvement of HIV Envelope Protein Expression and Yield DAIDS R43, R44 Standard dates through 2019-04-06.
PA-16-182, Strategies for the Improvement of HIV Envelope Protein Expression and Yield DAIDS R41, R42 Standard dates through 2019-04-06.
RFA-AI-16-009, NIAID SBIR-Technology Transfer Direct Phase II DEA R44 2016-06-23
PAR-16-027, SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance and Late Stage Development DAIDS, DAIT, DMID SB1 Standard dates through 2017-04-06.
PA-16-288, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp) DAIDS, DAIT, DMID Supp. See PA. Through 2019-09-30.
PA-16-289, Research Supplements to Promote Re-entry Into Biomedical and Behavioral Research Careers (Admin Supp) DAIDS, DAIT, DMID Supp. See PA. Through 2019-09-30.
PA-15-065, Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) DAIT R43, R44 Standard dates through 2018-01-08.
PA-14-154, Early-Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science DAIDS, DAIT, DMID R43, R44 Standard dates through 2017-05-08.
PA-14-157, Early-Stage Development of Technologies in Biomedical Computing, Informatics, and Big Data Science DAIDS, DAIT, DMID R41, R42 Standard dates through 2017-05-08.
PAR-15-288, Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science DAIDS, DAIT, DMID R44 Standard dates through 2017-04-06.
PAR-14-088, Direct Phase II SBIR Grants to Support Biomedical Technology Development DAIDS, DAIT, DMID R44 Standard dates through 2017-01-08.
PA-14-102, Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) DAIDS R41, R42 Standard dates through 2017-01-08.
PA-14-101, Innovative Technologies and Assays in Support of HIV Cure Research (ITAS-Cure) DAIDS R43, R44 Standard dates through 2017-01-08.
PA-14-308, Platform Delivery Technologies for Nucleic Acid Therapeutics DAIDS R41, R42 Standard dates through 2016-09-08.
PA-14-307, Platform Delivery Technologies for Nucleic Acid Therapeutics DAIDS R43, R44 Standard dates through 2016-09-08.
​​

Last Updated June 06, 2016

Last Reviewed June 06, 2016